135 related articles for article (PubMed ID: 34205269)
1. Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study.
Pérez-Rubio G; López-Flores LA; Cupertino AP; Cartujano-Barrera F; Reynales-Shigematsu LM; Ramírez M; Ellerbeck EF; Rodríguez-Bolaños R; Falfan-Valencia R
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34205269
[TBL] [Abstract][Full Text] [Related]
2. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
[TBL] [Abstract][Full Text] [Related]
4. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
[TBL] [Abstract][Full Text] [Related]
5. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.
Malaiyandi V; Lerman C; Benowitz NL; Jepson C; Patterson F; Tyndale RF
Mol Psychiatry; 2006 Apr; 11(4):400-9. PubMed ID: 16402128
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment: A pilot study.
Pérez-Rubio G; López-Flores LA; García-Carmona S; García-Gómez L; Noé-Díaz V; Ambrocio-Ortiz E; Nava-Quiroz KJ; Morales-González F; Del Angel-Pablo AD; Ramírez-Venegas A; Sansores RH; Falfán-Valencia R
Gene; 2019 Apr; 694():93-96. PubMed ID: 30738094
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
Ezzeldin N; El-Lebedy D; Darwish A; El Bastawisy A; Abd Elaziz SH; Hassan MM; Saad-Hussein A
BMC Cancer; 2018 May; 18(1):525. PubMed ID: 29724170
[TBL] [Abstract][Full Text] [Related]
8. CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.
Cannon DS; Mermelstein RJ; Medina TR; Pugach O; Hedeker D; Weiss RB
Nicotine Tob Res; 2016 May; 18(5):637-41. PubMed ID: 26541911
[TBL] [Abstract][Full Text] [Related]
9. CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer.
Styn MA; Nukui T; Romkes M; Perkins KA; Land SR; Weissfeld JL
Subst Use Misuse; 2013 May; 48(7):490-4. PubMed ID: 23528144
[TBL] [Abstract][Full Text] [Related]
10. Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.
Fogli S; Saba A; Del Re M; Pistelli F; Aquilini F; Zucchi R; Palla A; Breschi MC; Carrozzi L; Danesi R
J Pharm Biomed Anal; 2016 Nov; 131():208-213. PubMed ID: 27599351
[TBL] [Abstract][Full Text] [Related]
11. Associations of CYP2A6 genotype with smoking behaviors in southern China.
Liu T; David SP; Tyndale RF; Wang H; Zhou Q; Ding P; He YH; Yu XQ; Chen W; Crump C; Wen XZ; Chen WQ
Addiction; 2011 May; 106(5):985-94. PubMed ID: 21205058
[TBL] [Abstract][Full Text] [Related]
12. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
[TBL] [Abstract][Full Text] [Related]
13. CYP2A6 metabolism in the development of smoking behaviors in young adults.
Olfson E; Bloom J; Bertelsen S; Budde JP; Breslau N; Brooks A; Culverhouse R; Chan G; Chen LS; Chorlian D; Dick DM; Edenberg HJ; Hartz S; Hatsukami D; Hesselbrock VM; Johnson EO; Kramer JR; Kuperman S; Meyers JL; Nurnberger J; Porjesz B; Saccone NL; Schuckit MA; Stitzel J; Tischfield JA; Rice JP; Goate A; Bierut LJ
Addict Biol; 2018 Jan; 23(1):437-447. PubMed ID: 28032407
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity.
Pérez-Rubio G; Ramírez-Venegas A; Noé Díaz V; García Gómez L; Elvira Fabián K; García Carmona S; López-Flores LA; Ambrocio-Ortiz E; Contreras Romero R; Alcantar-Ayala N; Sansores RH; Falfán-Valencia R
PLoS One; 2017; 12(1):e0170019. PubMed ID: 28103253
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study of smoking behaviours in patients with COPD.
Siedlinski M; Cho MH; Bakke P; Gulsvik A; Lomas DA; Anderson W; Kong X; Rennard SI; Beaty TH; Hokanson JE; Crapo JD; Silverman EK; ;
Thorax; 2011 Oct; 66(10):894-902. PubMed ID: 21685187
[TBL] [Abstract][Full Text] [Related]
16. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation program and CYP2A6 polymorphism.
Ozaki S; Oyama T; Isse T; Kagawa N; Uramoto H; Sugio K; Yasumoto K; Kono K; Kawamoto T
Front Biosci; 2006 Sep; 11():2590-7. PubMed ID: 16720336
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
[TBL] [Abstract][Full Text] [Related]
19. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
[TBL] [Abstract][Full Text] [Related]
20. Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review.
Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
Nicotine Tob Res; 2022 Mar; 24(5):633-642. PubMed ID: 34478556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
